Tags

Type your tag names separated by a space and hit enter

Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester.
J Clin Gastroenterol. 2007 Nov-Dec; 41(10):894-900.JC

Abstract

BACKGROUND

The biologic significance of nuclear factor-kappaB (NF-kappaB) activation in human gastric cancer is unclear. We clarify the clinical significance of NF-kappaB activation and its relationship to Helicobacter pylori infection, a well-known pathogenesis of gastric cancer. Moreover, we examine the effects and underlying mechanisms induced by caffeic acid phenethyl ester (CAPE), an inhibitor of NF-kappaB, for gastric carcinoma.

METHODS

NF-kappaB was located immunohistochemically in 90 human gastric cancer specimens and 50 nonmalignant gastric specimens. The correlations between NF-kappaB activation, pathologic staging, and H. pylori infection were analyzed. We also performed electrophoretic mobility gel shift assay, real-time reverse transcription polymerase chain reaction, and enzyme-linked immunosorbent assay to evaluate the responses of AGS (a gastric adenocarcinoma epithelial cell line) human gastric cancer cells subsequent to H. pylori infection or CAPE treatment.

RESULTS

Nuclear expression of NF-kappaB was significantly more frequently observed in gastric cancer tissues than in nonmalignant gastric tissues (31% vs. 4%, P=0.0001). The activity of NF-kappaB and the expressions of MMP-9, IL-1beta, and IL-8 in AGS cells were activated by H. pylori infection. However, the augmented responses could be significantly reversed by CAPE treatment. Moreover, in vitro studies showed that CAPE inhibits tumor growth and capacity for invasion.

CONCLUSIONS

NF-kappaB activation is related to carcinogenesis, tumor aggression, and H. pylori infection with the increased expression of MMP-9, IL-1beta, and IL-8. Moreover, NF-kappaB inhibitors or anti-inflammatory agents such as CAPE might be new adjuvant agent against invasive gastric carcinoma.

Authors+Show Affiliations

Department of Gastroenterology, Chang Gung Memorial Hospital, Chia-Yi, Putz City, Chia-Yi Hsien, Taiwan. gi_cgmh@yahoo.com.twNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18090157

Citation

Wu, Cheng-Shyong, et al. "Predictive Role of Nuclear factor-kappaB Activity in Gastric Cancer: a Promising Adjuvant Approach With Caffeic Acid Phenethyl Ester." Journal of Clinical Gastroenterology, vol. 41, no. 10, 2007, pp. 894-900.
Wu CS, Chen MF, Lee IL, et al. Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester. J Clin Gastroenterol. 2007;41(10):894-900.
Wu, C. S., Chen, M. F., Lee, I. L., & Tung, S. Y. (2007). Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester. Journal of Clinical Gastroenterology, 41(10), 894-900.
Wu CS, et al. Predictive Role of Nuclear factor-kappaB Activity in Gastric Cancer: a Promising Adjuvant Approach With Caffeic Acid Phenethyl Ester. J Clin Gastroenterol. 2007 Nov-Dec;41(10):894-900. PubMed PMID: 18090157.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester. AU - Wu,Cheng-Shyong, AU - Chen,Miao-Fen, AU - Lee,I-Lin, AU - Tung,Shui-Yi, PY - 2007/12/20/pubmed PY - 2008/1/23/medline PY - 2007/12/20/entrez SP - 894 EP - 900 JF - Journal of clinical gastroenterology JO - J Clin Gastroenterol VL - 41 IS - 10 N2 - BACKGROUND: The biologic significance of nuclear factor-kappaB (NF-kappaB) activation in human gastric cancer is unclear. We clarify the clinical significance of NF-kappaB activation and its relationship to Helicobacter pylori infection, a well-known pathogenesis of gastric cancer. Moreover, we examine the effects and underlying mechanisms induced by caffeic acid phenethyl ester (CAPE), an inhibitor of NF-kappaB, for gastric carcinoma. METHODS: NF-kappaB was located immunohistochemically in 90 human gastric cancer specimens and 50 nonmalignant gastric specimens. The correlations between NF-kappaB activation, pathologic staging, and H. pylori infection were analyzed. We also performed electrophoretic mobility gel shift assay, real-time reverse transcription polymerase chain reaction, and enzyme-linked immunosorbent assay to evaluate the responses of AGS (a gastric adenocarcinoma epithelial cell line) human gastric cancer cells subsequent to H. pylori infection or CAPE treatment. RESULTS: Nuclear expression of NF-kappaB was significantly more frequently observed in gastric cancer tissues than in nonmalignant gastric tissues (31% vs. 4%, P=0.0001). The activity of NF-kappaB and the expressions of MMP-9, IL-1beta, and IL-8 in AGS cells were activated by H. pylori infection. However, the augmented responses could be significantly reversed by CAPE treatment. Moreover, in vitro studies showed that CAPE inhibits tumor growth and capacity for invasion. CONCLUSIONS: NF-kappaB activation is related to carcinogenesis, tumor aggression, and H. pylori infection with the increased expression of MMP-9, IL-1beta, and IL-8. Moreover, NF-kappaB inhibitors or anti-inflammatory agents such as CAPE might be new adjuvant agent against invasive gastric carcinoma. SN - 0192-0790 UR - https://www.unboundmedicine.com/medline/citation/18090157/Predictive_role_of_nuclear_factor_kappaB_activity_in_gastric_cancer:_a_promising_adjuvant_approach_with_caffeic_acid_phenethyl_ester_ L2 - https://doi.org/10.1097/MCG.0b013e31804c707c DB - PRIME DP - Unbound Medicine ER -